Focus: Saluda Medical is an Australia-based medical device company specializing in spinal cord stimulation (SCS) technology for chronic pain management. The company focuses on closed-loop, smart SCS systems with applications across neurology and musculoskeletal indications.
Profile data last refreshed 1h ago · AI intelligence enriched 2w ago
Stable — net +2 jobs in 30d
12 added, 10 removed. Backfill posture.
Best suited for commercial, sales, and market expansion professionals seeking established medical device growth; research-focused candidates should investigate pipeline maturity and regulatory pathway clarity.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Lead product with multi-indication expansion including chemotherapy-induced peripheral neuropathy and chronic pelvic pain, driving 82% of pipeline activity.
Help build intelligence for Saluda Medical
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Saluda Medical's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Based on last 4 crawl cycles
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo